Latest News

Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases

Scientists report an advance toward "structure-based drug design," with the potential to delay or treat Alzheimer's disease, Parkinson's disease, type II diabetes, ALS (also known as Lou Gehrig's disease) and many other degenerative diseases.
View full story

Post your comment.


  • Should women consume alcohol during pregnancy?

  • Extremely active rats become lazy when they artificially receive 'runners' high'

  • Youngest students in class 30% more likely to die in suicide than older classmates, Japanese study shows

  • Repeating aloud to another person boosts recall

  • American placebo: New analysis of chronic pain drug trials shows increasing placebo responses over time, in the US only

  • Understanding others' thoughts enables young kids to lie

  • Mutation involved in neurodegeneration discovered

  • How dominant parents affect kids' self-worth

  • Virus-drug combination shows improved effectiveness against brain tumor cells

  • Risk profiling is key to managing pain in era of opioid abuse